Systematic inflammatory response using heparin-coated cardiopulmonary bypass circuits-A comparison with non-coated equipments

Japanese Journal of Artificial Organs

Volumn 27, Issue 2, 1998, Pages 413-417

  Takeda, F ^a   Inui, K ^a   Watanabe, T ^a   Kuraoka, S ^a   Iizima, Y ^a   Minowa, T ^a   Miura, M ^a   Uchino, H ^a   Shimazaki, Y ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Aprotinin; Cytokines; Heparin coating; Thrombomodulin; XIIa

Indexed keywords

APROTININ; BLOOD CLOTTING FACTOR 12A; CYTOKINE; HEPARIN; THROMBOMODULIN;

ARTICLE; BIOCOMPATIBILITY; CARDIOPULMONARY BYPASS; DEVICE; INFLAMMATION; OPEN HEART SURGERY; VALVULAR HEART DISEASE;

EID: 0031862516     PISSN: 03000818     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Banfreton C, Jansen PGM, Le Besnerais P, te Velthuis H, Thijs CM, Wildevuur CRH, Loisanee DY: Heparin Coating With Aprotinin Reduces Blood Activation During Coronary Artery OperationsAnn Thorac Surg 63:50, 1997.
2. Kuitunen AH, Heikkila LJ, Salmenpera MT: Cardiopulmonary Bypass With Heparin-Coated Circuits and Reduced Systemic Anticoagulation. Ann Thorac Surg 63:438,1997.
3. Borowiec JW, Bylock A, van der Linden J, Thelin S: Heparin Coating Reduces Blood Cell Adhesion to Arterial Filters During Coronary Bypass A Clinical Study. Ann Thorac Surg 55:1540,1993.
4. Weerwind PW, Maessen JG, van Tits LJH, Stad RK, Fransen EJ, de Jong DS, Penn OCKM: Influence of Duraflo II Heparin-Treated Exlracorponeal Circuits on the Systemic Inflammatory Response in Patients Having Coronary Bypass. J Thorac Cardiovasc Surg 110:1033, 1995.
5. Nakajima T, Osawa S, Ogawa M, Sasaki T, Izumato H, Yagi Y, Kawazoe K: Clinical Study of Platelet Function and Coagulation/Fibrinolysis With Duraflo II Heparin Coated Cardiopulmonary Bypass Equipment. ASAIO Journal 42:301,1996.
6. Westaby S: Aprotinin in Perspective. Ann Thorac Surg 55:1033,1993.
7. Saito H: Contact Factors in Health and Disease. Semin Thromb Hemost 13:36,1987.
8. Usui A, Hiroura M, Kawamura M, Hibi M, Yoshida K, Murakami F, Tomita Y, Ooshima H, Murase M: Nafamostat Mesilate Reduces Blood-Foreign Surface Reactions Similar to Biocompatible Materials. Ann Thorac Surg 62:1404,1996.
9. Gu YJ, van Oeveren W, van der Kamp KWHJ, Akkerman C, Boonstra PW, Wildervuur ChRH: Heparin-Coating of Extracorponeal Circuits Reduces Thrombin Formation in Patients Undergoing Cardiopulmonary Bypass. Perfusion 6:221,1991.
10. Orchard MA, Goodchild CS, Prentice CRM, Davies JA, Benoit SE, Creighton-Kemsford LJ, Gaffney PJ, Michelson AD: Aprotinin Reduces Cardiopulmonary Bypass-Induced Blood Loss and Inhibits Fibrinolysis Without Influencing Platelets. British Journal of Hematology 85: 533,1993.
11. Hattler BG, Zeevi A, Oddis CV, Kinkel MS: Cytokine Induction During Cardiac Surgery. Analysis of TNF α Expression Pre-and Postcardiopulmonary Bypass. J Card Surg 10:418, 1995
12. Engelman RM, Rouson JA, Flack III JE, Deaton DW, Kalfin R, Das DK: Influence of Steroids on Complement and Cytokine Generation After Cardiopulmonary Bypass. Ann Thorac Surg 60: 801,1995.